Dr. Mark Alan Schrumpf, MD

Dr. Schrumpf practices at California Pacific Orthopaedics in San Francisco, California.

Dr. Schrumpf's NPI, 1467648139, was assigned on September 17, 2007. Dr. Schrumpf graduated from Keck School of Medicine of USC in 2007. Dr. Schrumpf holds California license A118035.

Dr. Schrumpf's primary practice is California Pacific Orthopaedics, at 3838 California St Rm 516 Rm 516, San Francisco, CA 94118-1507. The practice phone is (415) 668-8010.

Dr. Schrumpf's primary practice is California Pacific Orthopaedics in San Francisco, California. Dr. Schrumpf is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is California Pacific Orthopaedics. Dmand AI also links Dr. Schrumpf to 4 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schrumpf practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Schrumpf's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Schrumpf is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Schrumpf's licenses on file in 2 states: California and New York.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, carpal tunnel syndrome, enthesopathy in arms, fluid in a joint, hip replacement and joint arthropathy among the conditions Dr. Schrumpf treats.

CMS data shows 3,052 Medicare services from Dr. Schrumpf across 14 procedure codes in 2024, for 576 Medicare patients. Medicare paid $182,423 for them.

CMS counts 576 Medicare patients who saw Dr. Schrumpf in 2024. The largest group is 65 to 74, with 258 patients. 75% of them have high cholesterol, and 74% have arthritis. 10% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schrumpf's median patient age at 69, with 46% women.

In 2024, Dr. Schrumpf wrote 132 Medicare Part D claims for 72 patients. 99% of them were for generic drugs. CMS names the drug for 82 of them, across 5 drugs with 11 or more claims each, at $432 in total drug cost. In 2023, CMS named 105 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Schrumpf for performance year 2024, reported as part of a group. Dr. Schrumpf accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schrumpf as offering telehealth. CMS counts 22 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Schrumpf, more than 66% of the clinicians it reports for that procedure.

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Schrumpf, published from 2013 to 2022. 2014 was the busiest year, with 2. The most frequent topics are Range of Motion, Articular, Radiography and Reoperation. Dr. Schrumpf has published most often in J Shoulder Elbow Surg. Dr. Schrumpf's most frequent co-authors are James Damian Kelly, MD, Arthur Ta-Tzu Lee, MD and Di Lin Parks, MD.

CMS Open Payments shows 129 general payments to Dr. Schrumpf from 12 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 65% of the total. Shoulder Innovations, Inc. paid the most, $266,847.

Dr. Schrumpf graduated from Keck School of Medicine of USC in 2007.

Dr. Schrumpf is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.